Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Open-market buy Director bought 64,350 shares at an average $188.47 ($12,128,340)
  2. 4 Open-market buy Director bought 67,079 shares at an average $178.11 ($11,947,280)
  3. 4 Open-market buy Director bought 49,387 shares at an average $158.13 ($7,809,559)
  4. 4 Open-market buy Director bought 107,499 shares at an average $146.99 ($15,801,021)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award President and CEO acquired 50,000 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 1,198 shares (grant or award)
  9. 4 Grant or award Director acquired 1,198 shares (grant or award)
  10. 4 Grant or award Director acquired 1,198 shares (grant or award)
  11. 4 Grant or award Director acquired 1,198 shares (grant or award)
  12. 4 Grant or award Director acquired 9,584 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Senior VP, Chief Pharma Dev. sold 10,000 shares at an average $273.24 ($2,732,438)
  16. 4 Open-market sale Director sold 22,489 shares at an average $293.15 ($6,592,686)
  17. 4 Grant or award Chief Commercial Officer acquired 15,001 shares (grant or award)
  18. 4 Grant or award Senior VP, Chief Pharma Dev. acquired 5,667 shares (grant or award)
  19. 4 Grant or award SVP and General Counsel acquired 15,001 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 15,001 shares (grant or award)

Page 8 of 29 · 564 filings